Qiu, Caixin
Wu, Hao
Xu, Peng
Owusu, Nana K.
Glaser, Kevin J.
Li, Jiahui
Simonetto, Douglas A.
Venkatesh, Sudhakar K.
Shen, Wen
Manduca, Armando
Shah, Vijay H.
Ehman, Richard L.
Yin, Meng https://orcid.org/0000-0001-6778-192X
Funding for this research was provided by:
U.S. Department of Defense (PR181303, W81XWH-19-1-0583)
National Institutes of Health (R01 EB017197, R01 DK132718, R01 DK136731, UH3 AA026887, R37 EB001981, R37 AA021171, UH3 AA026887)
Article History
Received: 12 February 2025
Revised: 17 June 2025
Accepted: 1 July 2025
First Online: 4 August 2025
Compliance with ethical standards
:
: The scientific guarantor of this publication is Meng Yin.
: The Mayo Clinic, Richard L. Ehman, Kevin J. Glaser, and Meng Yin have intellectual property rights and a financial interest in MRE technology.
: Not applicable.
: This study was conducted in accordance with the Declarations of Helsinki and Istanbul and was approved by the Mayo Clinic Institutional Review Board. This study included two cohorts: cohort one was a retrospective study, and cohort two was a prospective study. In cohort one, the informed consent requirement was waived. In cohort two, written informed consent was obtained from all patients.
: Institutional Review Board approval was obtained.
: Some study subjects or cohorts have been previously reported in JMRI [].
: